A new study found that GLP-1 weight-loss drugs with the active ingredient liraglutide can significantly reduce migraines.

GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...

Medications such as Ozempic and Saxenda have grown in popularity due to their ability to treat type 2 diabetes and assist in ...

In a randomized trial of 2.4-mg semaglutide, 3.0-mg liraglutide, and matching placebo for both, those on semaglutide plus diet and exercise saw a 9.4% greater average loss in baseline weight ...

Study: One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice.Image Credit: Pixel-Shot / Shutterstock.com. A recent JAMA Network Open study compares the weight loss ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.

The research suggests that liraglutide, a drug originally developed for diabetes (Victoza) and weight management (Saxenda), may significantly reduce the frequency of debilitating migraine.

Lupin receives USFDA approval for generic diabetes medications, including Liraglutide Injection and Glucagon for Injection.

The liraglutide group also showed greater improvements in glycated hemoglobin level, plasma glucose level, and other measures of glucose control. Furthermore, ...

In that study, DehydraTECH-liraglutide outperformed the Rybelsus® control group by week 12 both in terms of blood sugar and body weight control, by 11.53% (p<0.0001) and 11.13% (p=0.0395 ...

SAN FRANCISCO —The glucagon-like peptide-1 (GLP-1) agonist liraglutide (Victoza, Novo Nordisk) taken every day preserved postprandial insulin secretion for 1 year after type 1 diabetes diagnosis ...

Liraglutide concentrations were measured with a radioimmunoassay specific for the intact N-terminus of GLP-1 using liraglutide as standard and antibody code no. 98302. 10 This assay would in ...